Specific neuropsychiatric symptoms are associated with shorter survival time from mild Alzheimer’s d...

The Food and Drug Administration approved the New Drug Application for Namzaric to treat moderate to...

More than half of seniors--55 percent--with dementia had no history of cognitive evaluations, report...

While previous research has shown a link between benzodiazepines and acute cognitive function, a lin...

A panel of neurocognitive experts from the University of Michigan and Johns Hopkins University propo...

The United States Preventive Services Task Force (USPSTF) has concluded that evidence is insufficien...

Though elevated levels of apolipoprotein E (APOE) was initially recognized as a protective factor ag...

On Friday, the Food and Drug Administration (FDA) approved Vizamyl (flutemetamol) for use with posit...

Diabetes is a known risk factor for dementia. Now some of the major factors that determine whether a...